HYASYNTH BIO
We make Better Cannabinoids through sustainable biotechnology.
HYASYNTH BIO
Industry:
Biopharma Biotechnology Cannabis Cosmetics Pharmaceutical
Founded:
2014-05-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.hyasynthbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
OrganiGram
OrganiGram investment in Debt Financing - Hyasynth Bio
OrganiGram
OrganiGram investment in Corporate Round - Hyasynth Bio
OrganiGram
OrganiGram investment in Corporate Round - Hyasynth Bio
Groupe Roski
Groupe Roski investment in Corporate Round - Hyasynth Bio
Anges Quebec
Anges Quebec investment in Seed Round - Hyasynth Bio
Hedgewood
Hedgewood investment in Seed Round - Hyasynth Bio
InnoStart Capital
InnoStart Capital investment in Seed Round - Hyasynth Bio
SOSV
SOSV investment in Seed Round - Hyasynth Bio
RebelBio
RebelBio investment in Seed Round - Hyasynth Bio
RebelBio
RebelBio investment in Convertible Note - Hyasynth Bio
Official Site Inspections
http://www.hyasynthbio.com
- Host name: baltar.asoshared.com
- IP address: 143.95.40.48
- Location: Los Angeles United States
- Latitude: 34.0549
- Longitude: -118.2578
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90014
More informations about "Hyasynth Bio"
Hyasynth Bio
We're a biology company based in Montreal, Canada. Our main focus is on engineering microbes for the manufacturing of pharmaceuticals and other products.See details»
Hyasynth Bio - Crunchbase Company Profile & Funding
Organization. Hyasynth Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; We’re a …See details»
Hyasynth Biologicals Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hyasynth Biologicals Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Hyasynth Bio - LinkedIn
Hyasynth Bio | 2,756 followers on LinkedIn. Biology for people. Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every …See details»
Hyasynth completes key commercialization milestone for …
Oct 23, 2020 Hyasynth receives $2.5 million milestone payment following first-to-market achievement with CBD produced by fermentation. MONTREAL, Oct. 23, 2020 /CNW Telbec/ - …See details»
Hyasynth Bio - Products, Competitors, Financials, Employees ...
Hyasynthbio.com. Overview & Products; Financials; People; Alternatives & Competitors; Customers; Founded Year 2014. Stage Seed - III | Alive. Total Raised $11.62M. Last Raised …See details»
hyasynth
Oct 23, 2020 MONCTON, New Brunswick — () — As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company…See details»
Organigram Confirms Additional $2.5 Million Investment in …
Hyasynth Investment. MONCTON, New Brunswick — As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram …See details»
Hyasynth: A Founder’s Journey from iGEM to Start-up — iGEM Blog
Mar 18, 2020 To follow our story and look out for job postings, you can keep an eye out on our website and newsletter at hyasynthbio.com ... Foundation is an independent, non-profit …See details»
Hyasynth Bio - Craft
Hyasynth Bio is a company that focuses on engineering microbes for the manufacturing of pharmaceuticals. It produces and distributes cannabinoid products designed to treat …See details»
Hyasynth first to market with CBD in global race to commercialize ...
Sep 28, 2020 Hyasynth marks landmark commercial achievement. MONTREAL, Sept. 28, 2020 /CNW Telbec/ -- Hyasynth, a sustainable biotechnology company, takes top spot from global …See details»
Organigram Makes Additional $2.5 Million Investment in Hyasynth ...
Dec 22, 2021 As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “OrgSee details»
Interview with Kevin Chen | CEO & Co-founder | Hyasynth Bio
Aug 15, 2016 Hyasynth is creating a new class of drugs, based around the phytocannabinoids. We’re changing the supply chain and making it easy for companies and investors to fund new …See details»
Hyasynth bio increases its research on cannabinoids and other …
A direct release from the company is available at: https://blog.hyasynthbio.com. Information and interviews. François St-Gelais +1 418 815-0803. [email protected]. Share. We use …See details»
About - hyasynth
CEO & Co-founder of @hyasynthbio, Co-founder of @bricobioMTL, writing about science, cannabis, startups and also juggling. Blocked Unblock Follow Following. Writers. Elizabeth …See details»
Hyasynth is officially a Licensed Dealer of Cannabinoids
Feb 16, 2018 A security camera that we had installed as part of the requirements for becoming a licensed dealer. This isn’t required for research exemptions.See details»
Hyasynth announces production of >20 rare cannabinoids by …
May 27, 2021 Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel biosynthesis pathwaySee details»
Organigram Confirms Additional $2.5 Million Investment in
Oct 23, 2020 As an early investor in biosynthesis, Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce …See details»
Hyasynth Bio - VentureRadar
Website: http://hyasynthbio.com/ Offers cost-effective, large-scale production of medical cannabis compounds, including THC and CBD, using engineered yeast for ...See details»
FAO in Syria|Newsdetails
1 day ago In addition, the Organization provided a comprehensive technical capacity building to train technical staff in efficient bio-agent production and release, beside conducting an …See details»